New York Regional Center for Diabetes Translation Research

纽约糖尿病翻译研究区域中心

• 批准号: 10290452
• 负责人: JEFFREY S GONZALEZ
• 金额: $ 22.28万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-20 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10290452
• 关键词: Advisory Committees; Awareness; Behavioral Sciences; Biometry; Communities; Consultations; Country; Development; Diabetes Mellitus; Disadvantaged; Doctor of Philosophy; Ensure; Ethics; Evaluation; Evolution; Faculty; Funding; Funding Opportunities; Goals; Grant; Growth; Health; Health system; Infrastructure; Institutes; Institution; Investments; Latino; Leadership; Life Cycle Stages; Maintenance; Medicine; Mentors; Methodology; Mission; National Institute of Diabetes and Digestive and Kidney Diseases; New York; Obesity; Outcome; Performance; Procedures; Process; Productivity; Program Evaluation; Quality Control; Reporting; Research; Research Design; Research Personnel; Research Proposals; Resources; Services; System; Technology; Time; Translational Research; Translations; United States National Institutes of Health; Vision; Work; base; college; cost efficient; diabetes risk; expectation; flexibility; health equity; improved; innovation; interest; member; next generation; population health; programs; racial and ethnic; racial minority; success; translational scientist; web site

Administrative Core The Administrative (ADM) Core of the New York Regional Center for Diabetes Translation Research (NY- CDTR) provides the fundamental infrastructure necessary to strengthen such research at the Albert Einstein College of Medicine with Montefiore Health Systems, and other diverse partnering institutions of our Core faculty and members to stimulate the next generation of diabetes translation research through the following aims: 1) To provide dynamic and responsive leadership. The ADM will afford consistent scientific leadership to articulate and implement a clear vision for the translational research direction of the Center. The Program Director, Jeffrey Gonzalez, PhD, will provide strong and responsive leadership to accelerate translational research on diabetes and obesity that contributes to health equity in diabetes outcomes for ethnic/racial minorities, the poor and disadvantaged, and other marginalized groups. 2) To provide robust infrastructure for the maintenance of four cutting edge Translational Research Cores. We have developed and refined four Translational Research Cores furnishing the infrastructural bedrock of the NY-CDTR: Behavioral Science and Technology Core; Life Course Methodology Core; Population Health and Health Systems Core; and the Latino Network for Diabetes Translation Research, a National Resource Core. 3) To administer vibrant Center Programs, including an Enrichment Program and a Pilot and Feasibility (P&F) Grant Program. The ADM will leverage the many resources of our collaborating academic institutions, funded Centers and CTSAs, so that the Enrichment Program activities are accessible for members as well as potential new members; there is also a heightened awareness of the wealth of educational programs for diabetes translational investigators focused on health equity research. The ADM will also provide infrastructure and support for the robust, mentored P&F Program to fund promising research proposals from early stage investigator members. Maintenance of a useful and up-to-date NY-CDTR website will make these resources accessible to our members and non-members across the country. We will also stimulate and promote use of diversity supplements throughout our national network. 4) To objectively evaluate progress, facilitate efficiency, and ensure ethical conduct of research, and quality control, with guidance from multi-stakeholder and community-based advisors. The ADM institutes a system of reportage and evaluation to ensure that services meet expectations; initiatives continue to be effective; progress is reported in a timely and comprehensive manner; and established objectives continue to be met. The ADM will work with an Internal Advisory Committee and External Scientific Advisory Committee to ensure the cost-efficient and high impact performance of all Center activities to guide the evolution of the NY- CDTR toward the next generation of diabetes translation research that is responsive to community needs and priorities, funding opportunities, and developments in technology.

行政核心 纽约糖尿病翻译研究区域中心 (NY- CDTR）提供了加强阿尔伯特·爱因斯坦研究所的此类研究所需的基础设施 医学院与 Montefiore Health Systems 以及我们核心的其他多元化合作机构 教职员工和成员通过以下方式刺激下一代糖尿病转化研究 目标： 1) 提供充满活力和反应灵敏的领导力。 ADM 将提供一致的科学领导 阐明并实施该中心转化研究方向的明确愿景。该计划 董事 Jeffrey Gonzalez 博士将提供强有力且反应迅速的领导力，以加速转化 关于糖尿病和肥胖症的研究有助于种族/种族糖尿病结局的健康公平 少数民族、穷人和弱势群体以及其他边缘群体。 2) 提供强大的基础设施 维护四个尖端转化研究核心。我们开发并完善了四种 转化研究核心为 NY-CDTR 提供基础设施：行为科学和 技术核心；生命历程方法论核心；人口健康和卫生系统核心；和拉丁裔 糖尿病翻译研究网络，国家资源核心。 3) 管理充满活力的中心 计划，包括丰富计划和试点与可行性 (P&F) 资助计划。 ADM 将 利用我们合作的学术机构、资助中心和 CTSA 的众多资源，以便 会员和潜在新会员均可参加丰富计划活动；还有 提高对针对糖尿病转化研究人员的丰富教育计划的认识 健康公平研究。 ADM 还将为强大的、受指导的 P&F 提供基础设施和支持 资助早期研究人员有前途的研究提案的计划。维护有用的 最新的 NY-CDTR 网站将使我们的会员和非会员可以访问这些资源 全国各地。我们还将刺激和促进在全国范围内使用多样性补充剂 网络。 4) 客观评估进展、提高效率并确保研究行为符合道德规范，以及 在多利益相关者和社区顾问的指导下进行质量控制。 ADM 设立了 报告和评估系统，以确保服务达到期望；举措继续 有效的;及时、全面地报告进展情况；和既定目标继续 被满足。 ADM 将与内部咨询委员会和外部科学咨询委员会合作， 确保所有中心活动具有成本效益和高影响力，以指导纽约的发展 CDTR 面向下一代糖尿病转化研究，响应社区需求和 优先事项、融资机会和技术发展。